Ravi Viswanathan, 10% Owner at AVEO PHARMACEUTICALS INC (AVEO), bought 420,658 shares at $2.13 ($897K) on 2018-05-17, disclosed to the SEC on 2018-05-21.
Open-market purchase of $897k AVEO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.13 | 184,179 | $392K | 43.8% |
| 2 | $2.13 | 184,179 | $392K | 43.8% |
| 3 | $2.14 | 20,100 | $43K | 4.8% |
| 4 | $2.14 | 32,200 | $69K | 7.7% |
| Total | $2.13 avg | 420,658 | $897K | 100% |
| Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |